Quarterly report · Q2
3645.TEDINET S100PYWE
Period2022-06-01 → 2022-11-30
Filed2023-01-16
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.0bn | 2022-06-01 → 2022-11-30 | Cons. | Net sales |
| Revenue | ¥3.7bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.7bn | 2021-06-01 → 2021-11-30 | Cons. | Net sales |
| Operating income | ¥192m | 2022-06-01 → 2022-11-30 | Cons. | Operating income |
| Operating income | ¥249m | 2021-06-01 → 2021-11-30 | Cons. | Operating income |
| Ordinary income | ¥220m | 2022-06-01 → 2022-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥454m | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥247m | 2021-06-01 → 2021-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥221m | 2022-06-01 → 2022-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥329m | 2021-06-01 → 2021-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥131m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥385m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥247m | 2021-06-01 → 2021-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥144m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss |
| Net income | ¥250m | 2021-06-01 → 2021-11-30 | Cons. | Profit loss |
| Total assets | ¥3.4bn | at 2022-11-30 | Cons. | Assets |
| Total assets | ¥3.2bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥2.6bn | at 2021-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2022-11-30 | Cons. | Liabilities |
| Total liabilities | ¥1.4bn | at 2022-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2022-11-30 | Cons. | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.6bn | at 2021-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.2bn | at 2022-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.2bn | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥951m | at 2021-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥869m | at 2021-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥59m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥343m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥85m | 2021-06-01 → 2021-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥32m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥355m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥68m | 2021-06-01 → 2021-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥906,000 | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥282m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥70m | 2021-06-01 → 2021-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥14.74 | 2022-06-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.19 | 2022-09-01 → 2022-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.98 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.42 | 2021-06-01 → 2021-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.39 | 2021-09-01 → 2021-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 56.0% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.1% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.3% | at 2021-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 45
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2022-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥2,000 |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥297m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥12,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥25m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥213,000 |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥66m |
| —segment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| —segment total | segment profit | 2022-06-01 → 2022-11-30 | ¥389m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-11-30 | ¥390m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-06-01 → 2021-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-06-01 → 2021-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-06-01 → 2021-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2021-06-01 → 2021-11-30 | ¥483m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2021-06-01 → 2021-11-30 | ¥483m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2021-06-01 → 2021-11-30 | ¥326m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2021-06-01 → 2021-11-30 | ¥76m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2021-06-01 → 2021-11-30 | ¥76m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥8,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2021-06-01 → 2021-11-30 | ¥32m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2021-06-01 → 2021-11-30 | ¥1.1bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2021-06-01 → 2021-11-30 | ¥1.1bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥19,000 |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2021-06-01 → 2021-11-30 | ¥77m |
| —segment total | revenue | 2021-06-01 → 2021-11-30 | ¥1.7bn |
| —segment total | revenue external | 2021-06-01 → 2021-11-30 | ¥1.7bn |
| —segment total | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥28,000 |
| —segment total | segment profit | 2021-06-01 → 2021-11-30 | ¥436m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2021-11-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2021-11-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-06-01 → 2021-11-30 | ¥28,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2021-11-30 | ¥437m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 492
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E24982-000MediaplatformReportableSegmentsMember | 326264000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | 77326000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E24982-000MedicalBToBReportableSegmentsMember | 31931000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 435522000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1809000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 437332000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E24982-000MediaplatformReportableSegmentsMember | 499169000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | 1414039000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E24982-000MedicalBToBReportableSegmentsMember | 82958000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 1996167000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1812000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 1997979000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E24982-000MediaplatformReportableSegmentsMember | 2000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | 213000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E24982-000MedicalBToBReportableSegmentsMember | 12000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 228000 | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 228000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E24982-000MediaplatformReportableSegmentsMember | 499172000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | 1414252000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E24982-000MedicalBToBReportableSegmentsMember | 82970000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 1996395000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1812000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 1998207000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E24982-000MediaplatformReportableSegmentsMember | 296978000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | 66141000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E24982-000MedicalBToBReportableSegmentsMember | 25419000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 388539000 | JPY |
| Operating income | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1812000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 390351000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-01-16 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第22期第２四半期（自 2022年９月１日 至 2022年11月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社メディカルネット | |
| Company name in english cover page | FilingDateInstant | Medical Net, Inc. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役会長CEO 平川 大 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都渋谷区幡ヶ谷一丁目34番14号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | （03）5790－5261 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)管理本部ゼネラルマネージャー 三宅 大祐 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都渋谷区幡ヶ谷一丁目34番14号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | （03）5790－5261 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)管理本部ゼネラルマネージャー 三宅 大祐 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E24982 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 36450 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社メディカルネット | |
| Filer name in english | FilingDateInstant | Medical Net, Inc. |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |